Skip to main content
logo
Outlook Therapeutics, Inc. (OTLK)
NASDAQ: OTLK · Real-Time Price · USD
0.9545
+0.0415 (4.55%)
Aug 4, 2026, 2:15 PM EDT - Market open

Outlook Therapeutics Revenue

Outlook Therapeutics had revenue of $127.44K in the quarter ending March 31, 2026. This brings the company's revenue in the last twelve months to $333.14K. In the fiscal year ending September 30, 2025, Outlook Therapeutics had annual revenue of $1.41M.

Revenue (ttm)
$333.14K
Revenue Growth
n/a
P/S Ratio
499.63
Revenue / Employee
$19,597
Employees
17
Market Cap
178.49M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Sep 30, 20251.41M--
Sep 30, 2024---
Sep 30, 2023---
Sep 30, 2022---
Sep 30, 2021---
Sep 30, 2020---
Sep 30, 20198.15M5.06M163.84%
Sep 30, 20183.09M-723.96K-18.99%
Sep 30, 20173.81M831.94K27.92%
Sep 30, 20162.98M-2.24M-42.91%
Sep 30, 20155.22M-3.83M-42.33%
Sep 30, 20149.05M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Protalix BioTherapeutics76.38M
Precision BioSciences45.07M
Voyager Therapeutics36.49M
MediWound14.48M
Alpha Cognition10.83M
Camp4 Therapeutics3.93M
Humacyte2.02M
Revenue Rankings

OTLK News

More News